Brain signals could Fine-Tune Parkinson's treatment
NCT ID NCT07369310
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using brain imaging and electrical signals to program deep brain stimulation (DBS) works better than the usual method for people with Parkinson's disease. Twenty adults aged 30 to 70 who are getting DBS will be randomly assigned to either standard programming or a biomarker-guided approach. The goal is to see if the new method reduces daily 'off' time and improves quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Deep brain stimulation (DBS) programming guided by biomarkers (brain imaging and beta brain signals)
- What this could lead to
- If successful, this approach could make DBS programming more precise, reducing daily 'off' time and improving quality of life for people with Parkinson's.
- What could go wrong
- This is a small, early-stage trial with only 20 participants, so results may not apply to everyone. The biomarker-guided method may not outperform standard programming in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DBS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain imaging may reveal who benefits from deep brain stimulation for Parkinson's freezing
- High-Resolution brain scans aim to unmask Tau's role in Parkinson's
- Can brain stimulation sharpen Decision-Making in Parkinson's?
- Can Stem-Cell implants restore movement in Parkinson's?
- Gene mutation may amplify cognitive risks of brain stimulation in Parkinson's
- Brain implant for Parkinson's may raise fall risk — a study investigates